| Title |
The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®
|
|---|---|
| Published in |
EJNMMI Research, January 2014
|
| DOI | 10.1186/2191-219x-4-2 |
| Pubmed ID | |
| Authors |
Alexander H Staudacher, Fares Al-Ejeh, Cara K Fraser, Jocelyn M Darby, David M Roder, Andrew Ruszkiewicz, Jim Manavis, Michael P Brown |
Mendeley readers
The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 29 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 21% |
| Student > Master | 6 | 21% |
| Student > Bachelor | 5 | 17% |
| Student > Ph. D. Student | 4 | 14% |
| Other | 3 | 10% |
| Other | 0 | 0% |
| Unknown | 5 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 24% |
| Agricultural and Biological Sciences | 5 | 17% |
| Biochemistry, Genetics and Molecular Biology | 4 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 10% |
| Chemistry | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 9 | 31% |